Cargando…
Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19
As a result of the coronavirus 2019 (Covid-19) pandemic, clinical research for substance use disorders (SUDs) has been impeded due to widespread stay-at-home mandates limiting the operations of “non-essential” work. Although appropriate to proceed with an abundance of caution to prevent viral spread...
Autores principales: | Brezing, Christina A., Luo, Sean X., Mariani, John J., Levin, Frances R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647443/ https://www.ncbi.nlm.nih.gov/pubmed/32956164 http://dx.doi.org/10.1097/ADM.0000000000000733 |
Ejemplares similares
-
Applications of technology in the assessment and treatment of cannabis use disorder
por: Brezing, Christina A., et al.
Publicado: (2022) -
The Rise of Prescription Digital Therapeutics in Behavioral Health
por: Brezing, Christina A., et al.
Publicado: (2022) -
Patient Engagement With a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder: Protocol for a Randomized Controlled Open-Label, Decentralized Trial
por: Luderer, Hilary, et al.
Publicado: (2022) -
Longitudinal Analysis of Substance Use Disorder Symptom Severity at Age 18 Years and Substance Use Disorder in Adulthood
por: McCabe, Sean Esteban, et al.
Publicado: (2022) -
Substance use, mental disorders and COVID-19: a volatile mix
por: Marel, Christina, et al.
Publicado: (2021)